Evidence map›Paper›PMID 28898696›Full record

ArticleCancer cell2017

A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.

Yannick Boege, Mohsen Malehmir, Marc E Healy, Kira Bettermann, Anna Lorentzen, Mihael Vucur, Akshay K Ahuja, Friederike Böhm, Joachim C Mertens, Yutaka Shimizu and 43 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Molecular mechanisms in MASLD/MASH-related HCC.Hepatology (Baltimore, Md.) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 6 countries.

Yannick BoegeDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Mohsen MalehmirDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Marc E HealyDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Kira BettermannDepartment of Translational Inflammation Research, Institute of Experimental Internal Medicine, Otto von Guericke University, 39120 Magdeburg, Germany.
Anna LorentzenInstitute of Virology, Technische Universität München, Helmholtz Zentrum München, 85764 Munich, Germany.
Mihael VucurDepartment of Medicine III, Division of GI and Hepatobiliary Oncology, University Hospital RWTH Aachen, 52056 Aachen, Germany.
Akshay K AhujaInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Friederike BöhmDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Joachim C MertensGastroenterology and Hepatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Yutaka ShimizuCentre for Cell Death, Cancer, and Inflammation, Department of Cancer Biology, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
Lukas FrickDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Caroline RemouchampsLaboratory of Molecular Immunology and Signal Transduction, GIGA-R, University of Liège, 4000 Liège, Belgium.
Karun MutrejaInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Thilo KähneInstitute of Experimental Internal Medicine, Otto von Guericke University, 39120 Magdeburg, Germany.
Devakumar SundaravinayagamDNA Repair and Maintenance of Genome Stability, Max-Delbruck Center for Molecular Medicine (MDC) Berlin, 13125 Berlin, Germany.
Monika J WolfDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Hubert RehrauerFunctional Genomics Center Zurich, ETH and University Zurich, 8057 Zurich, Switzerland.
Christiane KoppeDepartment of Medicine III, Division of GI and Hepatobiliary Oncology, University Hospital RWTH Aachen, 52056 Aachen, Germany.
Tobias SpeicherDepartment of Biology, Institute of Molecular Health Sciences, ETH, Zurich, Switzerland.
Susagna Padrissa-AltésDepartment of Biology, Institute of Molecular Health Sciences, ETH, Zurich, Switzerland.
Renaud MaireDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Jörn M SchattenbergI. Department of Medicine, University Medical Center, Johannes Gutenberg-University, 55122 Mainz, Germany.
Ju-Seong JeongDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.
Lei LiuDepartment of Surgery, Technische Universität München, 80333 Munich, Germany.
Stefan ZwirnerDepartment of Internal Medicine VIII, University Hospital Tübingen, 72076 Tübingen, Germany; Department of Physiology I, Institute of Physiology, Eberhard Karls University Tübingen, 72076 Tübingen, Germany; Translational Gastrointestinal Oncology Group, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Regina BogerNational Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Norbert HüserDepartment of Surgery, Technische Universität München, 80333 Munich, Germany.
Roger J DavisHoward Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Beat MüllhauptGastroenterology and Hepatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Holger MochDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Henning Schulze-BergkamenNational Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Pierre-Alain ClavienClinic of Visceral and Transplantation Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Sabine WernerDepartment of Biology, Institute of Molecular Health Sciences, ETH, Zurich, Switzerland.
Lubor BorsigInstitute of Physiology, University of Zurich, 8057 Zurich, Switzerland.
Sanjiv A LutherDepartment of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland.
Philipp J JostIII. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Ricardo WeinlichDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Kristian UngerResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Axel BehrensAdult Stem Cell Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Laura HillertDepartment of Translational Inflammation Research, Institute of Experimental Internal Medicine, Otto von Guericke University, 39120 Magdeburg, Germany.
Christopher DillonDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Michela Di VirgilioDNA Repair and Maintenance of Genome Stability, Max-Delbruck Center for Molecular Medicine (MDC) Berlin, 13125 Berlin, Germany.
David WallachDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.
Emmanuel DejardinLaboratory of Molecular Immunology and Signal Transduction, GIGA-R, University of Liège, 4000 Liège, Belgium.
Lars ZenderDepartment of Internal Medicine VIII, University Hospital Tübingen, 72076 Tübingen, Germany; Department of Physiology I, Institute of Physiology, Eberhard Karls University Tübingen, 72076 Tübingen, Germany; Translational Gastrointestinal Oncology Group, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Michael NaumannInstitute of Experimental Internal Medicine, Otto von Guericke University, 39120 Magdeburg, Germany.
Henning WalczakCentre for Cell Death, Cancer, and Inflammation, Department of Cancer Biology, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Massimo LopesInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Inna LavrikDepartment of Translational Inflammation Research, Institute of Experimental Internal Medicine, Otto von Guericke University, 39120 Magdeburg, Germany.
Tom LueddeDepartment of Medicine III, Division of GI and Hepatobiliary Oncology, University Hospital RWTH Aachen, 52056 Aachen, Germany.
Mathias HeikenwalderDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland; Institute of Virology, Technische Universität München, Helmholtz Zentrum München, 85764 Munich, Germany; Institute of Chronic Inflammation and Cancer, Deutsches Krebs-Forschungszentrum (DKFZ), 69120 Heidelberg, Germany. Electronic address: m.heikenwaelder@dkfz.de.
Achim WeberDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, 8091 Zurich, Switzerland. Electronic address: achim.weber@usz.ch.
University Hospital of Zurich · CHOtto-von-Guericke University Magdeburg · DEUniversity of Zurich · CHETH Zurich · CHRWTH Aachen University · DESt. Jude Children's Research Hospital · USTechnical University of Munich · DEHelmholtz Zentrum München · DEMax Delbrück Center · DENational Center for Tumor Diseases · DEUniversity of Liège · BEWeizmann Institute of Science · ILCRUK Lung Cancer Centre of Excellence · GBGerman Cancer Research Center · DEHoward Hughes Medical Institute · USKlinikum rechts der Isar · DEThe Francis Crick Institute · GBUniversity College London · GBUniversity Medical Center of the Johannes Gutenberg University Mainz · DEUniversity of Lausanne · CH

Funding

Survival Function of the Fadd-Caspase-8-Flip ComplexR01AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1999 to 2016
$6.3M
Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT ExtensionR37AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · 2017 to 2026
$4.5M
Metabolic Stress SignalingR01DK107220 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DAVIS, ROGER J. · 2016 to 2023
$3.6M
NIAID NIH HHS R01 AI044828NIAID NIH HHS R37 AI044828NIDDK NIH HHS R01 DK107220
6 · The paper itself

Abstract

Concomitant hepatocyte apoptosis and regeneration is a hallmark of chronic liver diseases (CLDs) predisposing to hepatocellular carcinoma (HCC). Here, we mechanistically link caspase-8-dependent apoptosis to HCC development via proliferation- and replication-associated DNA damage. Proliferation-associated replication stress, DNA damage, and genetic instability are detectable in CLDs before any neoplastic changes occur. Accumulated levels of hepatocyte apoptosis determine and predict subsequent hepatocarcinogenesis. Proliferation-associated DNA damage is sensed by a complex comprising caspase-8, FADD, c-FLIP, and a kinase-dependent function of RIPK1. This platform requires a non-apoptotic function of caspase-8, but no caspase-3 or caspase-8 cleavage. It may represent a DNA damage-sensing mechanism in hepatocytes that can act via JNK and subsequent phosphorylation of the histone variant H2AX.

Indexed as

DNA DamageAnimalsApoptosisCarcinogenesisCarcinoma, HepatocellularCaspase 8Cell ProliferationCellular SenescenceChronic DiseaseCrosses, GeneticDNA RepairFas-Associated Death Domain ProteinFemaleGenomic InstabilityHepatectomyHepatocytesCaspase 8Fadd protein, mouseFas-Associated Death Domain Proteingamma-H2AX protein, mouseHistonesJNK Mitogen-Activated Protein KinasesMcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 ProteinReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type IRipk1 protein, mouseapoptosisDNA damage responsehepatocellular carcinomaliverreplication stress

Identifiers

PMID28898696
PMCPMC5598544
OpenAlexW2756470947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.